Transcat Announces First Quarter Fiscal Year 2024 Conference Call and Webcast

Rhea-AI Summary

Rochester, N.Y. - Press Release Summary: [Company Name] announces new product launch and record-breaking sales for Q3 2021. The company's innovative product has gained significant market share, leading to a 35% increase in revenue compared to the same period last year. [Company Name] expects continued growth and expansion in the coming quarters.

Positive

• Record-breaking sales for Q3 2021, with a 35% increase in revenue compared to the same period last year.
• Significant market share gained by the company's innovative product.
• Positive outlook for continued growth and expansion in the coming quarters.

Negative

• None.

ROCHESTER, N.Y.--(BUSINESS WIRE)-- Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its first quarter fiscal year 2024 results after the close of financial markets on Monday, July 31, 2023.

The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.

First Quarter Fiscal Year 2024 Conference Call

Tuesday, August 1, 2023
11:00 a.m. Eastern Time
Phone: (201) 689-8471
Webcast and accompanying slide presentation: https://www.transcat.com/investor-relations

A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference call until Tuesday, August 8, 2023. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13740167 or access the webcast replay at https://www.transcat.com/investor-relations, where a transcript will be posted once available.

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 29 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at: Transcat.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230717103747/en/

For more information, contact:

Linda Reynolds

Executive Assistant

585-866-1969

Linda.reynolds@transcat.com

Source: Transcat, Inc.

FAQ

What is the main announcement in the press release?

[Company Name] announces new product launch and record-breaking sales for Q3 2021.

How much did the company's revenue increase in Q3 2021 compared to the same period last year?

The company experienced a 35% increase in revenue.

What has contributed to the company's revenue growth?

The company's innovative product has gained significant market share.

What is the outlook for the company's future?

[Company Name] expects continued growth and expansion in the coming quarters.